In this section, we will explore whether people with sulfa allergies can safely take semaglutide
This is a controlled substance and must not be stopped abruptly
2026 Guideline on the Management of Dyslipidemia Updated: March 13, 2026 This guideline retires and replaces the 2018 AHA/ACC Guideline on the Management of Blood Cholesterol and is retitled the 2026 Guideline on the Management of Dyslipidemia to reflect the evolving understanding of atherosclerotic cardiovascular disease (ASCVD) risk associated with atherogenic lipoproteins beyond low-density lipoprotein cholesterol (LDL-C), including triglyceride-rich remnant particles and lipoprotein(a) [Lp(a)]
According to a study published in the Journal of the American Medical Association , patients on GLP-1 therapies experience significantly higher rates of gastrointestinal adverse events compared with non-users
Additional safety areas under monitoring include heart rate changes, muscle mass preservation, and thyroid C-cell effects
A recent study reported that the novel mitophagy inducer miriplatin-loaded liposomes (LMPt) enhance LONP1 binding to polymerase gamma (POLG) and TFAM, thereby resulting in POLG and TFAM degradation, which inhibits mtDNA replication and suppresses pancreatic cancer cell proliferation [160]